Zusammenfassung
Das Muir-Torre-Syndrom ist eine sehr seltene phänotypische Variante des hereditären nonpolypösen kolorektalen Karzinoms. Es ist gekennzeichnet durch das gemeinsame Auftreten mindestens eines Talgdrüsentumors mit gastrointestinalen und urogenitalen Tumoren. Anhand der Kasuistik eines 72-jährigen Patienten, der zur Exzision eines Oberlidtumors zugewiesen wurde, soll der Weg vom klinischen Befund bis zur seltenen Diagnose dargestellt werden.
Abstract
Muir-Torre syndrome is a rare autosomal dominant subtype of hereditary nonpolyposis colorectal carcinoma and is characterized by the simultaneous occurrence of sebaceous gland neoplasms with visceral and urogenital malignancies. This article describes the case of a 72-year-old patient who was referred to our clinic for removal of an upper eyelid tumor, showing the course from the clinical findings to the rare diagnosis of Muir-Torre syndrome.
This is a preview of subscription content, log in via an institution to check access.
Literatur
Muir EG, Bell AJ, Barlow KA (1967) Multiple primary carcinomata of the colon, duodenum, and larynx associated with kerato-acanthomata of the face. Br J Surg 54(3):191–195
Plaschke J, Engel C, Kruger S et al (2004) Lower incidence of colorectal cancer and later age of disease onset in 27 families with pathogenic MSH6 germline mutations compared with families with MLH1 or MSH2 mutations: the German Hereditary Nonpolyposis Colorectal Cancer Consortium. J Clin Oncol 22(22):4486–4494
Wijnen J, Leeuw W de, Vasen H et al (1999) Familial endometrial cancer in female carriers of MSH6 germline mutations. Nat Genet 23(2):142–144
Mangold E, Rahner N, Friedrichs N et al (2007) MSH6 mutation in Muir-Torre syndrome: Could this be a rare finding? Br J Dermatol 156(1):158–162
Arnold A, Payne S, Fisher S et al (2007) An individual with Muir-Torre syndrome found to have a pathogenic MSH6 gene mutation. Fam Cancer 6(3):317–321
Murphy HR, Armstrong R, Cairns D, Greenhalgh KL (2008) Muir-torre syndrome: expanding the genotype and phenotype – a further family with a MSH6 mutation. Fam Cancer 7(3):255–257
Kacerovska D, Cerna K, Martinek P et al (2012) MSH6 mutation in a family affected by Muir-Torre syndrome. Am J Dermatopathol 34(6):648–652
Tavakkol Z, Keller JJ, Furmanczyk PS et al (2012) Germline mutation in MSH6 associated with multiple malignant neoplasms in a patient with Muir-Torre syndrome. J Clin Oncol 30(22):e195–e198
Meyer LA, Broaddus RR, Lu KH (2009) Endometrial cancer and lynch syndrome: clinical and pathologic considerations. Cancer Control 16(1):14–22
Graefe T, Wollina U, Schulz H, Burgdorf W (2000) Muir-Torre syndrome – treatment with isotretinoin and interferon alpha-2a can prevent tumour development. Dermatology 200(4):331–333
Negraszus N, Joehrens K, Bertelmann E (2010) Patientin mit Muir Torre Syndrom. Ophthalmologe 2010(11):1059–1062
Interessenkonflikt
Die korrespondierende Autorin gibt für sich und ihre Koautoren an, dass kein Interessenkonflikt besteht.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Voigt, E., Sommer, F., Geiger, K. et al. Talgdrüsenkarzinom mit seltener Genmutation im Rahmen eines Tumorsyndroms. Ophthalmologe 111, 369–372 (2014). https://doi.org/10.1007/s00347-013-2879-x
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00347-013-2879-x